Objective-To investigate the relationship between 3 markers of apoptosis, that is, FADD (Fas-associated death domaincontaining protein), caspase-3, and caspase-8, and incidence of coronary events (CEs) in a population-based cohort study. Approach and Results-In vitro experiments were performed to assess the response of the apoptotic biomarkers after Fas stimulation of peripheral blood mononuclear cells. The experiments showed significantly increased releases of FADD, caspase-3, and caspase-8 after Fas stimulation. The relationship between FADD, caspase-3, and caspase-8, respectively, and incidence of CEs was studied in 4284 subjects from the population-based Malmö Diet and Cancer Study. Cox' proportional hazards regression was used to examine the association between the apoptotic biomarkers and incidence of CE over a mean follow-up of 19 years. A total of 381 individuals had CE during the follow-up. High FADD at baseline was significantly associated with incident CE. In the highest compared with the lowest quartile of FADD, the risk factor adjusted hazards ratio for CE was 1.82 (95% confidence interval, 1.35-2.46; P for trend <0.001). A significant association was also found between caspase-8 and CE; the hazards ratio (Q4 versus Q1) was 1.90 (95% confidence interval, 1.39-2.60; P for trend <0.001) after adjustment for risk factors. No association was found between caspase-3 and CEs. Conclusions-High levels of FADD and caspase-8, but not caspase-3, were associated with increased incidence of CE in subjects from the general population. The in vitro experiments support the view that these biomarkers could reflect activation of the extrinsic apoptotic pathway. Visual Overview-An online visual overview is available for this article. marrow from mice with macrophages resistant to apoptosis resulted in increased plaque development. 12,13 However, others have found that reduced macrophage apoptosis is associated with less plaque necrosis and lesion progression.
A poptosis is a highly regulated program of cell death and can be mediated by death receptors in the plasma membrane, as well as the mitochondria and the endoplasmic reticulum. 1, 2 The initiation of apoptosis can be classified as intrinsic apoptotic pathway, which is initiated when facing cellular stress, and extrinsic apoptotic pathway, which is activated by extracellular ligands via cell surface death receptors. 3, 4 The Fas ligand binds the Fas receptor and activates the death domains at the cytoplasmic tail of the receptor. The adaptor protein FADD (Fas-associated death domain-containing protein) will then be recruited and activate caspase-8, leading to either downstream activation of the intrinsic pathway by inducing mitochondrial stress or direct activation of executioner caspases (caspase-3, caspase-6, and caspase-7) to degrade cellular components. 3, 5 Analyses of human atherosclerotic plaques have shown that apoptotic cell death is a common phenomenon, 6 and it has been suggested that all plaque cells eventually become eliminated by apoptosis. 7 Apoptotic cell death represents a possibility to remove infiltrating leukocytes and injured vascular cells without aggravating inflammation. Although this may function appropriately at early stages of the disease, increased rates of apoptosis in more advanced lesions has been associated with insufficient removal of apoptotic cells, development of secondary necrosis, and aggravation of plaque inflammation. 6, 8 The effect of apoptosis on atherosclerotic plaques will also depend on which cells that primarily are affected. Smooth muscle and endothelial cell apoptosis is likely to be harmful by increasing the risk of plaque rupture and thrombosis. 9, 10 The majority of apoptotic cells in atherosclerotic plaques are macrophages, and apoptotic macrophages have been found to localize at the site of plaque rupture in sudden coronary death. 11 The role of macrophage apoptosis in atherosclerosis is more complex because it potentially can be both beneficial by reducing inflammation and harmful by inhibiting tissue repair responses orchestrated by these cells. Accordingly, experimental studies have identified both pro-and antiatherogenic effects of macrophage apoptosis in atherosclerosis. 6 Transplantation of hypercholesterolemic mice with bone marrow from mice with macrophages resistant to apoptosis resulted in increased plaque development. 12, 13 However, others have found that reduced macrophage apoptosis is associated with less plaque necrosis and lesion progression. 14, 15 Taken together, the available experimental and clinical data show that while apoptosis is a common phenomenon in atherosclerosis it remains to be fully understood if it contributes to an increased cardiovascular risk.
Prospective clinical studies of the association between apoptosis and risk for development of cardiovascular events have been hampered by the lack of circulating biomarkers of apoptosis. FADD, caspase-3, and caspase-8 can be measured in plasma in healthy individuals, but it is unclear to what extent they are released to blood as a result of ongoing apoptotic activity. Studies of patients with myocardial infarction have reported raised apoptotic markers in the acute phase after the event. 16, 17 However, to the best of our knowledge, there is no prospective study of FADD, caspase-3, or caspase-8 and the risk of developing acute coronary events (CEs). We demonstrate here that activation of the extrinsic apoptosis pathway through the Fas receptor in human mononuclear leukocytes is associated with release of FADD, caspase-8, and caspase-3 from the cells, suggesting that the plasma levels of these factors represent potential biomarkers of apoptosis. We then analyzed baseline levels of FADD, caspase-8, and caspase-3 in 4284 subjects participating in a Swedish population-based cohort study and explored the hypothesis that increased plasma levels of these biomarkers were associated with a higher incidence of CEs.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Activation of Apoptosis Through the Death Receptor Fas Is Associated With Release of Intracellular Components of Apoptotic Cell Signaling
Exposure of cultured human peripheral blood mononuclear cells to Fas ligand for 24 hours was associated with a dosedependent release of FADD, caspase-3, and caspase-8 into the cell culture medium ( Figure 1A) . A significant increase in the extracellular release of FADD and caspase-3 was observed at a Fas ligand concentration of 2.5 μg/mL and continued to increase at higher concentration, while a 4-fold higher concentration of Fas ligand was required to induce secretion of caspase-8. To determine whether release of intracellular components of apoptotic cell signaling occurred also in response to factors with cytotoxic properties, we incubated cultured human peripheral blood mononuclear cells with oxidized low-density lipoprotein (LDL) in concentrations ≤200 μg/mL. Although a small increase in the secretion of caspase-3 was observed at the 25 to 50 μg/mL of oxidized LDL, there was no induction of FADD and caspase-8 secretion ( Figure 1B) . Finally, we confirmed the release of FADD into the cell culture medium using Western blotting ( Figure 1C ). Taken together, these observations show that activation of apoptosis signaling through the Fas receptor is associated with extracellular release of FADD, caspase-8, and caspase-3 and suggests that circulating levels of these factors represent biomarkers of apoptotic activity.
Baseline Characteristics of the Study Cohort
We next investigated the association between plasma levels of FADD, caspase-8, and caspase-3 with incidence of CE in a prospective population cohort. The baseline demographic and clinical characteristics of participants in this cohort are shown in Table 1 . As expected, participants with CE during follow-up had higher systolic blood pressure (BP), LDL, C-reactive protein, and lower high-density lipoprotein at baseline. In addition, individuals with CE during follow-up had higher FADD (P<0.001), caspase-8 (P<0.001), and caspase-3 (P=0.046) at baseline.
Correlations Between FADD, Caspase-8, and Caspase-3 and Other Risk Factors
FADD showed significant correlations with advanced age, male sex, smoking, systolic BP, LDL, and C-reactive protein; caspase-8 showed significant correlations with advanced age, male sex, systolic BP, LDL, high-density lipoprotein (inversely), C-reactive protein, education level; caspase-3 showed significant correlations with male sex, smoking, systolic BP, and LDL in the adjusted model (Table I in the online-only Data Supplement). The bivariate correlation between caspase-3 and caspase-8 was 0.542; FADD correlated significantly with caspase-3 and caspase-8 (r=0.762 and r=0.732, respectively). Prevalence of carotid plaque was 35%, 32%, 35%, and 32%, respectively, in the first, second, third, and fourth quartiles of FADD. The corresponding prevalence for quartiles of caspase-8 were 34%, 33%, 31%, and 35%, respectively. For quartiles of caspase-3, carotid plaque was found in 38%, 33%, 32%, and 31%, respectively. All 3 apoptotic biomarkers were inversely associated with carotid plaque after adjustments for cardiovascular risk factors (Table I in 
Incidence of CE in Relation to FADD, Caspase-8, and Caspase-3
During the mean follow-up of 18.9±4.5 years (80 781 personyears), 381 subjects had a CE (4.72 per 1000 person-years). High FADD at baseline was significantly associated with incident CE. In the highest compared with the lowest quartile of FADD, the adjusted hazards ratio for CE was 1.82 (95% confidence interval [CI], 1.35-2.46; P for trend =0.001; Table 2 and Figure 2) . This relationship remained significant also after further adjustment for carotid plaque in a sensitivity analysis (hazards ratio, 1.86; 95% CI, 1.37-2.53; P for trend <0.001). The C statistics value for model 2 (excluding FADD) was 0.7401 (95% CI, 0.7163-0.7638) and increased to 0.7494 (95% CI, 0.7259-0.7729) when FADD was added to the model. FADD significantly improved the discriminatory value (C statistic) for incidence of CE with 0.0093 (P=0.006). There was no significant interaction between FADD and other cardiovascular risk factors with respect to incidence of CE. There was also no significant interaction between FADD and carotid plaque. A significant association was also noted between caspase-8 and CE. Compared with the lowest quartile of caspase-8, the adjusted hazards ratio for CE was 1.90 (95% CI, 1.39-2.60) in the highest quartile (P for trend =0.001; Table 3 and Figure 3 ). This relationship was unchanged after further adjustment for carotid plaque (hazards ratio, 1.91; 95% CI, 1.39-2.62; P for trend <0.001). The C statistics value increased to 0.7515 (95% CI, 0.7281-0.7749) when caspase-8 was added to the model 2 (difference in C statistics 0.0114; P=0.002). If FADD and caspase-8 simultaneously were added as continuous variables in model 2, caspase-8 was found to be significant (P=0.019) while FADD was not (P=0.25), and C statistics increased marginally (from 0.7515 to 0.7527). There was no significant interaction between caspase-8 and other cardiovascular risk factors (including carotid plaque) with respect to incidence of CE.
No association was found between caspase-3 and CE (Table 4 and Figure 4) .
Discussion
Our findings demonstrate that activation of apoptosis signaling through the Fas receptor is associated with a release of the intracellular apoptosis signaling components FADD, caspase-8, and caspase-3 into the extracellular compartment, suggesting that they represent possible biomarkers of apoptotic activity. Exposure of culture mononuclear leukocytes to a cytotoxic factor, such as oxidized LDL, did not stimulate the extracellular release of FADD and caspase-8, but induced some release of caspase-3 at intermediate concentration. These observations suggest that the cellular release of FADD and caspase-8 reflects activation of apoptosis, while the release of caspase-3 may reflect both apoptosis and cell cytotoxicity in a broader sense. In a population-based cohort, we demonstrate an association between incidence of CE and high levels of FADD and caspase-8 at baseline levels, but not caspase-3. Furthermore, FADD and caspase-8 significantly improved the model discrimination in terms of C statistics, on top of several conventional risk factors for CE, and could perhaps add information to a prediction model. The current findings supported our hypothesis that an increased rate of apoptosis, as represented by a high expression of FADD and caspase-8 in the blood, was associated with an increased incidence of CE.
Atherosclerotic vascular disease is a leading cause of myocardial infarction and heart failure, and a major factor in the development of acute coronary syndrome is disruption of an atherosclerotic plaque. 11 It has been reported that macrophages and smooth muscle cells undergo apoptosis in unstable atherosclerotic plaques, which can lead to rupture of the plaque and thrombosis, and finally cause acute myocardial infarction. 11, 18, 19 However, the role of apoptosis in atherosclerosis remains a matter of controversy because it potentially can have both beneficial and pathogenic effects. 6, 20 Apoptotic cell death in lesions is probably less harmful than necrotic cell death, which initiates inflammation and damage to neighboring cells. 21, 22 In contrast, apoptosis is an energy requiring form of programmed cell death, whereby damaged cells are removed without provoking inflammation. 23 The importance of this for atherosclerosis is exemplified by studies demonstrating that impaired removal of apoptotic cells in atherosclerotic plaques is associated with a progression of apoptotic cells into secondary necrosis, enhanced inflammation, and necrotic core expansion. 8, 24, 25 Moreover, Gautier et al 26 reported that increased macrophage apoptosis is associated with reduced atherosclerosis during early stages of the diseases but aggravates atherosclerosis at more advanced stages in cholesterol-fed apoe −/− mice. Taken together, the available experimental data suggest that apoptosis in atherosclerotic lesions may have both beneficial and harmful effects depending on location and disease stage.
Caspase-8 and FADD were associated with several known risk factors of CE, including advanced age, male sex, systolic BP, LDL, C-reactive protein, and smoking. However, all these correlations were weak, and the relationships between apoptotic biomarkers and incidence of CE were, therefore, only slightly reduced by extensive adjustments for risk factors. We also found inverse associations between the apoptosis markers and the occurrence of carotid plaque as assessed by ultrasonography. Together, these observations suggest that the concentration of apoptotic biomarkers is not mainly a question of atherosclerotic risk factors or atherosclerotic burden. Because apoptosis occurs in many tissues and cell types, the circulating apoptotic biomarkers may be of a nonvascular origin. However, experimental studies have identified both pro-and antiatherogenic effects of macrophage apoptosis in atherosclerosis, 6 and increased plaque development has been found in hypercholesterolemic mice that were treated with bone marrow from mice with macrophages resistant to apoptosis. 12, 13 Apoptotic macrophages have also been found to localize at the site of plaque rupture in sudden coronary death, 11 which suggest that apoptosis could be involved in plaque rupture. To what extent the plasma levels of FADD and caspase-8 reflect the activity of disease within lesions requires further investigation.
Even though all 3 apoptotic biomarkers were strongly correlated (all r>0.5), caspase-3 was not significantly associated with CE. It is known that caspase-8 can activate procaspase-3, which in turn can cleave and activate caspases 6 and 7, leading to characteristic cell changes and death. 27 The nonsignificant relationship between caspase-3 and incidence of CE could reflect the fact that apoptosis is a highly regulated and controlled process, and there may be other factors that inhibit or activate the apoptotic cascade. However, our experiments showed that caspase-3 may be released both from apoptosis and from cell cytotoxicity. Caspase-3 could, therefore, be less specific marker of apoptosis.
Strengths and Limitations
This study was based on a large number of subjects, a long follow-up period, and a large number of incident CE. CE included fatal or nonfatal myocardial infarction from the hospital discharge register and death because of ischemic heart disease outside the hospital. Data from the Hospital Discharge register have shown high case validity in previous studies. 28 The participation rate was ≈41% at the baseline examination in 1992 to 1994. One question is whether the cohort is representative for the general population. It has been shown that the overall mortality rates were higher in nonparticipants, 29 which is in line with most cohort studies. However, prevalence of smoking, obesity, and education level was largely similar in participants of Malmö Diet and Cancer study compared with the results from a mailed questionnaire from the same city, with a participation rate of 75%. 29 It is reasonable to think that the results could be generalized to the general adult population in Sweden.
Some risk factors could have changed over the follow-up period. For example, it is well known that many individuals in Sweden have quit smoking in the past decades. However, if anything, this would reduce the risk of CE in those who smoked at baseline and bias the results toward null.
Conclusion
Our results suggest that high levels of FADD and caspase-8 represent biomarkers of apoptosis and that elevated plasma levels of these markers are associated with increased incidence of CE. This relationship is independent of several potential confounding factors. FADD and caspase-8 significantly increased the model discrimination in terms of C statistics. Further research is required to confirm these findings and to explore the underlying mechanisms between raised apoptotic biomarkers and incidence of CE.
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